High-yield dividend stocks can be a great way to generate passive income, but only if the payouts are sustainable.
That’s why we screened for 10 high dividend-paying companies offering above-average dividend yields without stretching their payout ratios too far.
They’re backed by stable cash flows, healthy balance sheets, and management teams with a track record of rewarding shareholders. Analysts still think some of these stocks are undervalued as well.
Company Name (Ticker) | Dividend Yield | Analyst Upside |
BCE (BCE) | 6.3% | 4% |
Enbridge (ENB) | 6.2% | 9% |
Enterprise Products Partners (EPD) | 7.0% | 15% |
Brookfield Infrastructure Partners (BIP) | 5.5% | 26% |
ONEOK (OKE) | 5.1% | 26% |
Realty Income (O) | 5.6% | 7% |
LyondellBasell (LYB) | 8.5% | 8% |
Verizon (VZ) | 6.4% | 14% |
Chevron (CVX) | 4.5% | 6% |
AbbVie (ABBV) | 3.5% | 10% |
Unlock our Free Report: 5 undervalued compounders with upside based on Wall Street’s growth estimates that could deliver market-beating returns (Sign up for TIKR, it’s free) >>>
Enterprise Products Partners (EPD)
Enterprise Products Partners (EPD) owns a massive network of pipelines, terminals, and storage tanks that transport oil, natural gas, and petrochemicals across North America. It’s one of the most consistent dividend payers in the energy space.
EPD generated around $2 billion in distributable cash flow last quarter and maintains a payout ratio of about 79% of DCF. It has increased its distribution for nearly three decades and currently yields about 6.7%.
The business is built on long-term, fee-based contracts, giving it predictable cash flow that supports a reliable income stream for investors.
Value stocks like ONEOK in under a minute with TIKR (It’s free) >>>
ONEOK (OKE)

ONEOK (OKE) operates natural gas pipelines and just completed a major acquisition of Magellan Midstream, giving it more exposure to refined products and scale across the midstream sector.
The company generates about $3.5 billion in annual free cash flow and aims to keep its dividend payout ratio below 85%. It yields around 5% today and plans to grow its dividend over time while deleveraging its balance sheet.
With more diversified cash flows and a stronger asset base post-acquisition, OKE is positioned to deliver solid income and potential upside.
Track EPD’s financials, growth trends, and analyst forecasts on TIKR (it’s free)>>>
AbbVie (ABBV)
AbbVie (ABBV) is one of the largest drugmakers in the world, known for treatments like Humira, Skyrizi, and Rinvoq. It generates over $20 billion in annual operating cash flow and continues to invest heavily in its drug pipeline.
AbbVie’s dividend yield is currently around 3.5%, with a free cash flow payout ratio of roughly 74%. Even as Humira faces competition, the company’s newer drugs are gaining momentum and helping to offset the decline.
AbbVie has raised its dividend every year since it was spun off from Abbott and remains a go-to pick for dividend-focused investors looking for stability and growth.
Track AbbVie’s financials, growth trends, and analyst forecasts on TIKR (it’s free) >>>
Wall Street Analysts Are Bullish on These 5 Undervalued Compounders With Market-Beating Potential
TIKR just released a new free report on 5 compounders that appear undervalued, have beaten the market in the past, and could continue to outperform on a 1-5 year timeline based on analysts’ estimates.
Inside, you’ll get a breakdown of 5 high-quality businesses with:
- Strong revenue growth and durable competitive advantages
- Attractive valuations based on forward earnings and expected earnings growth
- Long-term upside potential backed by analyst forecasts and TIKR’s valuation models
These are the kinds of stocks that can deliver massive long-term returns, especially if you catch them while they’re still trading at a discount.
Whether you’re a long-term investor or just looking for great businesses trading below fair value, this report will help you zero in on high-upside opportunities.
Click here to sign up for TIKR and get our full report on 5 undervalued compounders completely free.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!